Las Vegas, NV -- (SBWIRE) -- 10/24/2013 -- Beststocksondemand.com, is a financial newsletter and blog focused on shedding light on under-discovered small cap companies. Our team of professionals from various backgrounds work diligently to bring our members the best penny stock picks, stock market commentary, and news on all types of OTCBB and Pink Sheet companies, SK3 Group Inc (OTCMKTS:SKTO), Nuvilex Inc (OTCMKTS:NVLX), BANCO DO BRASIL SA (OTCMKTS:BDORY), CAN-FITE BIOPHARMA (OTCMKTS:CANFY)
SK3 Group Inc (OTCMKTS:SKTO) opened the session at $0.01, remained amid the day range of $0.01 - $0.01, and closed the session at $0.0115. The stock showed a positive performance of 13.86% in previous trading session. The stock gained a volume of 11.78 million shares and the average volume of the stock remained 9.71 million shares. SK3 Group, Inc. (SK3), formerly CTT International Distributors Inc., is a development-stage company. The Company was formed by the merger of Slabsdirect.com, Inc. and CTT International Distributors Inc. SK3 has one subsidiary, CTT Distributors Ltd., which is the operating company. SK3 is in the e-commerce business and provides non-branded computer and electronic merchandise at discount prices to the Internet consumer through its Website www.cheaperthanthem.com.
For How Long SKTO Gloss will Attract Investors? Find out via this report
Nuvilex Inc (OTCMKTS:NVLX) traded with volume of 2.43 million shares in the prior session and the average volume of the stock remained 1.76 million shares. The 52 week range of the stock remained $0.02 - $0.22. The stock showed a positive movement of 0.26% and closed its session at $0.118. The market capitalization of the stock remained 75.07 million. Nuvilex, Inc. operates independently and through wholly owned subsidiaries. The Company is a biotechnology and life technology company with a specialty in living-cell encapsulation. It is focused on preparations for a new pancreatic cancer clinical trial through live-cell encapsulation of chemotherapeutic-converting cells.
Will NVLX Continue To Move Higher? Find Out Here
BANCO DO BRASIL SA (OTCMKTS:BDORY) exchanged 183,861 shares and the average volume remained 140,083 shares. The stock escalated 0.77 % and closed the session at $13.02. The beta of the stock remained 1.82.
Why Should Investors Buy BDORY After The Recent Gain? Just Go Here and Find Out
CAN-FITE BIOPHARMA (OTCMKTS:CANFY) gained volume of 137,877 shares, while the average volume remained 11,341 shares. The stock decreased -8.53 % and finished the session at $6.33. The EPS of the stock remained 1.10. The one month of the stock was 43.86% and three month trend remained positive 50.71 %.
Why Should Investors Buy CANFY After the Recent Fall? Just Go Here and Find Out
About:Best Stock on Demand
Beststocksondemand.com is an exciting online financial terminal where stock readers, traders and investors as well as market analysts can come to discover new opportunities, ideas, situations and news. Beststocksondemand.com goal is finding the most Undervalued or should we say Value Stocks or the Next Emerging Growth Stock that might be unnoticed by Wallstreet. Beststocksondemand.com is constantly searching for exceptional investment situations that can profit both investors and traders in order to grow their gains on a well balanced portfolio.
Beststocksondemand.com is also a well-respected marketing and research firm that mainly focuses on Best Stocks on Demand, Micro-Cap Stocks and Small Cap Stocks. Beststocksondemand.com uses its strategic corporate communication services to increase investor awareness of your company. We can support developing, emerging growth and deep-rooted companies in their marketing therefore creating a more dominant and operative investor alertness.
The assembled information disseminated by Beststocksondemand.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Beststocksondemand.com does expect that investors will buy and sell securities based on information assembled and presented in beststocksdaily.com. PLEASE always do your own due diligence, and consult your financial advisor.
Please read Our Full Disclaimer at: http://www.beststocksondemand.com/disclaimer.html
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)